Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Control for Laser Epilation in Pilonidal Disease
NCT06640946Phase 4Completed
- Start
- Nov 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in pilonidal disease (2 arms). Primary endpoint: Pain related to laser follicle ablation. Started Nov 2024; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
pilonidal disease
Beyond the preview
Go deeper on NCT06640946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06640946.